OncoTherapy Science Inc. | Ownership
Companies that own OncoTherapy Science Inc.
Siemens Fonds Invest GmbH
352,546
0.24%
11,500
0.04%
04/30/2018
SSgA Funds Management, Inc.
136,600
0.09%
400
0%
09/06/2018
Monega Kapitalanlagegesellschaft mbH
123,000
0.08%
0
0.03%
07/31/2018
TIAA-CREF Investment Management LLC
69,100
0.05%
0
0%
03/31/2018
Resona Bank Ltd. (Investment Management)
45,920
0.03%
45,920
0%
04/25/2017
UBS AG (Investment Management)
18,900
0.01%
0
0%
01/31/2018
Acadian Asset Management LLC
0
0%
-5,000
0%
06/30/2018
GO ETF Solutions LLP
0
0%
-112,700
0%
02/28/2018
MML Investment Advisers LLC
0
0%
-1,700
0%
06/30/2018
The Vanguard Group, Inc.
0
0%
-21,350
0%
07/31/2018
| Address |
Kanagawa Science Park R&D D Bldg.
Kawasaki Kanagawa 213
Japan
|
|
Employees
|
- |
| Website |
http://www.oncotherapy.co.jp |
| Updated |
07/08/2019 |
| OncoTherapy Science, Inc. engages in the research and development of pharmaceutical products. It focuses its research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan. |
